المؤلفون: Lightfoot, MDS, Dorayappan, KDP, Backes, FJ, Cohn, DE, Karlan, BY, She, JX, Karuppaiyah, S

مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis, Clinical sciences, Oncology and carcinogenesis, Reproductive medicine

URL الوصول: https://escholarship.org/uc/item/9x5359zz

المؤلفون: Nagel, CI, Backes, FJ, Donner, J, Bussewitz, E, Hade, EM, Cohn, DE, Eisenhauer, EL, O’Malley, DM, Fowler, JM, Copeland, LJ, Salani, R

مصطلحات موضوعية: Oncology, Adult, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Neutropenia, Carcinoma, Ovarian Epithelial, Article, Disease-Free Survival, Drug Administration Schedule, Young Adult, Internal medicine, medicine, Carcinoma, Humans, Progression-free survival, Neoplasms, Glandular and Epithelial, Survival rate, Aged, Retrospective Studies, Aged, 80 and over, Ovarian Neoplasms, Chemotherapy, Taxane, Dose-Response Relationship, Drug, business.industry, Obstetrics and Gynecology, Middle Aged, medicine.disease, Surgery, Survival Rate, Regimen, Female, Ovarian cancer, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e799be2b29c5b33925ada243ea374636
https://europepmc.org/articles/PMC4035808/

المؤلفون: Thigpen JT, Kim KH, Backes FJ, Copeland LJ

المصدر: Clinical Ovarian Cancer; Jun2008, Vol. 1 Issue 1, p16-21, 6p

المؤلفون: Meade CE; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America., Sinnott JA; Department of Statistics, The Ohio State University College of Arts and Sciences, Columbus, OH, United States of America., Backes FJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, OH, United States of America., Cosgrove CM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, OH, United States of America., Quick AM; Department of Radiation Oncology, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus, OH, United States of America., Trabert B; Department of Obstetrics and Gynecology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States of America., Plascak JJ; Division of Cancer Prevention and Control, Department of Internal Medicine College of Medicine, The Ohio State University, Columbus, OH, United States of America., Felix AS; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, United States of America. Electronic address: ashley.felix@osumc.edu.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Sep; Vol. 188, pp. 111-119. Date of Electronic Publication: 2024 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Genital Neoplasms, Female*/therapy , Genital Neoplasms, Female*/ethnology , Genital Neoplasms, Female*/mortality , Healthcare Disparities*/ethnology , Healthcare Disparities*/statistics & numerical data, Humans ; Female ; Middle Aged ; Aged ; United States/epidemiology ; Adult ; Academic Medical Centers/statistics & numerical data

المؤلفون: O'Malley DM; Gynecologic Oncology, James Cancer Center/The Ohio State University, Columbus, OH 43210, USA., Myers T; Obstetrics and Gynecology, UMass Chan Medical School, Springfield, MA 01199, USA., Wimberger P; Gynecology and Obstetrics, and Gynecological Oncology, Carl Gustav Carus University, Technische Universität Dresden, Dresden, 01307, Germany., Gorp TV; Division of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, BGOG, 3000, Belgium., Redondo A; Servicio de Oncología Médica, Hospital Universitario La Paz-IdiPAZ, Madrid, 28046, Spain., Cibula D; Department of Gynaecology, Obstetrics & Neonatology, General University Hospital in Prague & First Faculty of Medicine, Charles University, Prague, 120 00;110 00, Czech Republic., Nicum S; Oncology, University College London Hospitals NHS Foundation Trust, London, NW1 2BU, UK., Rodrigues M; Medical Oncology, Institut Curie., PSL Research University, INSERM U830, Paris, 75006, France., Backes FJ; Gynecologic Oncology, James Cancer Center/The Ohio State University, Columbus, OH 43210, USA., Barlin JN; Women's Cancer Care Associates, Albany Medical College, Albany, NY 12208, USA., Lewin SN; Gynecologic Oncology, Holy Name Medical Center, Teaneck, NJ 07666, USA., Lim P; Center of Hope, University of Nevada, Reno School of Medicine, Reno, NV 89557, USA., Pothuri B; Gynecologic Oncology, Perlmutter Cancer Center, NYU Langone Health, New York, NY 10016, USA., Diver E; Medical Affairs, ImmunoGen, Inc., Waltham, MA 02451, USA., Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust & Institute of Cancer Research, London, SW3 6JJ, UK., Lorusso D; Gynaecological Oncology Unit, Catholic University of Rome & Fondazione Policlinico Gemelli IRCCS, Rome, 00168,Italy.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Jul 31, pp. 1-14. Date of Electronic Publication: 2024 Jul 31.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

المؤلفون: Chambers L; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, Ohio., Haight P; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, Ohio., Chalif J; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, Ohio., Mehra Y; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Spakowicz D; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Backes FJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, Ohio., Cosgrove CM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, Ohio., O'Malley DM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, Columbus, Ohio., Vargas R; Division of Gynecologic Oncology, The Cleveland Clinic Foundation, Cleveland, Ohio., Corr BR; Division of Gynecologic Oncology, University of Colorado, Denver, Colorado., Bae-Jump VL; Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina., Arend RC; Department of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 2905-2909.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Disease Models, Animal* , Endometrial Neoplasms*/immunology , Endometrial Neoplasms*/pathology , Endometrial Neoplasms*/therapy , Immunotherapy*/methods , Translational Research, Biomedical* , Uterine Cervical Neoplasms*/immunology , Uterine Cervical Neoplasms*/therapy , Uterine Cervical Neoplasms*/pathology, Animals ; Female ; Humans ; Cell Line, Tumor

المؤلفون: Riedinger CJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Barrington DA; Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, USA., Nagel CI; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Khadraoui WK; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Haight PJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Tubbs C; Department of Pharmacy, The Ohio State University Wexner Medical Center, USA., Backes FJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Cohn DE; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., O'Malley DM; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Copeland LJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Chambers LM; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Apr; Vol. 183, pp. R1.

نوع المنشور: Journal Article; Retraction of Publication

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Riedinger CJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA. Electronic address: Courtney.Riedinger@osumc.edu., Barrington DA; Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, USA., Nagel CI; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Khadraoui WK; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Haight PJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Tubbs C; Department of Pharmacy, The Ohio State University Wexner Medical Center, USA., Backes FJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Cohn DE; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., O'Malley DM; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Copeland LJ; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA., Chambers LM; Department of Obstetrics and Gynecologic, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center/James Cancer Hospital, USA.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Apr; Vol. 183, pp. 78-84. Date of Electronic Publication: 2024 Mar 29.

نوع المنشور: Journal Article; Retracted Publication

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Endometrial Neoplasms*/drug therapy , Endometrial Neoplasms*/economics , Cost-Benefit Analysis* , Neoplasm Recurrence, Local*/economics , Neoplasm Recurrence, Local*/drug therapy , Antineoplastic Combined Chemotherapy Protocols*/economics , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use, Humans ; Female ; Middle Aged ; Aged ; Antibodies, Monoclonal, Humanized/economics ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/administration & dosage ; Quality-Adjusted Life Years

المؤلفون: Levine MD; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America. Electronic address: monica.levine@hoag.org., Wang H; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Sriram B; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Khan A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Senter L; Division of Human Genetics, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States of America., McLaughlin EM; Center for Biostatistics, The Ohio State University, Columbus, OH, United States of America., Bixel KL; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Chambers LM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Cohn DE; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Copeland LJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Cosgrove CM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Nagel CI; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., O'Malley DM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America., Backes FJ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Ohio State University, Columbus, OH, United States of America.

المصدر: Gynecologic oncology [Gynecol Oncol] 2024 Mar; Vol. 182, pp. 51-56. Date of Electronic Publication: 2024 Jan 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy, Doxorubicin/*analogs & derivatives, Humans ; Female ; Carcinoma, Ovarian Epithelial/drug therapy ; Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use ; Retrospective Studies ; Platinum/therapeutic use ; Neoplasm Recurrence, Local/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Polyethylene Glycols

المؤلفون: Khadraoui W; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus., Meade CE; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus., Backes FJ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute, Columbus., Felix AS; Division of Epidemiology, College of Public Health, The Ohio State University, Columbus.

المصدر: JAMA network open [JAMA Netw Open] 2023 Dec 01; Vol. 6 (12), pp. e2346494. Date of Electronic Publication: 2023 Dec 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

مواضيع طبية MeSH: Ethnicity* , Genital Neoplasms, Female*/epidemiology , Genital Neoplasms, Female*/therapy , Uterine Cervical Neoplasms* , Racial Groups* , Patient Participation*, Female ; Humans ; Retrospective Studies ; Clinical Trials as Topic ; Middle Aged ; Aged